 Webinar to discuss results on March 10, 2021 at 4:30 p.m. E.T SAN CLEMENTE, CA ACCESSWIRE March 8, 2021 ReShape Lifesciences Inc. OTCQB:RSLS, a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that it will report its fourth quarter and full year 2020 financial and operational results on Wednesday, March 10, 2021 after the close of the U.S. financial markets. 